P
Pierluigi Simonato
Researcher at University of Hertfordshire
Publications - 23
Citations - 1047
Pierluigi Simonato is an academic researcher from University of Hertfordshire. The author has contributed to research in topics: Anxiety & Medicine. The author has an hindex of 13, co-authored 18 publications receiving 888 citations. Previous affiliations of Pierluigi Simonato include University of Padua.
Papers
More filters
Journal ArticleDOI
Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project.
Ornella Corazza,Ornella Corazza,Sulaf Assi,Pierluigi Simonato,John Corkery,Francesco Saverio Bersani,Zsolt Demetrovics,Jacqueline L. Stair,Suzanne Fergus,Cinzia Pezzolesi,Manuela Pasinetti,Paolo Deluca,Colin Drummond,Zoe Davey,Ursula Blaszko,Jacek Moskalewicz,Barbara Mervó,Lucia Di Furia,Maggi Farre,Liv Flesland,Agnieszka Pisarska,Harry Shapiro,Holger Siemann,Arvid Skutle,Elias Sferrazza,Marta Torrens,F. Sambola,Peer van der Kreeft,Norbert Scherbaum,Fabrizio Schifano +29 more
TL;DR: The Recreational Drugs European Network project, funded by the European Commission, was implemented to improve the information stream to young people and professionals about effects/risks of NPS by identifying online products and disseminating relevant information through technological tools.
Journal ArticleDOI
Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine.
Ornella Corazza,Ornella Corazza,Fabrizio Schifano,Pierluigi Simonato,Suzanne Fergus,Sulaf Assi,Jacqueline L. Stair,John Corkery,Giuseppina Trincas,Paolo Deluca,Zoe Davey,Ursula Blaszko,Zsolt Demetrovics,Jacek Moskalewicz,Aurora Enea,Giuditta Di Melchiorre,Barbara Mervó,Lucia Di Furia,Magí Farré,Liv Flesland,Manuela Pasinetti,Cinzia Pezzolesi,Agnieszka Pisarska,Harry Shapiro,Holger Siemann,Arvid Skutle,Elias Sferrazza,Marta Torrens,Peer van der Kreeft,Daniela Zummo,Norbert Scherbaum +30 more
TL;DR: In this paper, a pharmacological, chemical and behavioural overview of methoxetamine is presented, which is a dissociative drug related to ketamine, with a much longer duration of action and intensity of effects.
Journal ArticleDOI
Following “the Roots” of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries
Eduardo Cinosi,Giovanni Martinotti,Pierluigi Simonato,Darshan Singh,Zsolt Demetrovics,Andres Roman-Urrestarazu,Francesco Saverio Bersani,Balasingam Vicknasingam,Giulia Piazzon,Jih-Heng Li,Wen Jing Yu,Máté Kapitány-Fövény,Judit Farkas,Massimo Di Giannantonio,Ornella Corazza +14 more
TL;DR: It is concluded that the use of kratom is not negligible, especially for self-medication, and more clinical, pharmacological, and socioanthropological studies as well as a better international collaboration are needed to tackle this marginally explored phenomenon.
Journal ArticleDOI
Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey
Pierluigi Simonato,Ornella Corazza,Paolo Santonastaso,John Corkery,Paolo Deluca,Zoe Davey,Ursula Blaszko,Fabrizio Schifano +7 more
TL;DR: Novel psychoactive substances (NPS) are advertised online as ‘safe’ and ‘legal’ natural/synthetic analogues of controlled illicit drugs, however, only little research has been carried out in identifying the health professionals' knowledge and expertise relating to the intake of these compounds.
Journal ArticleDOI
25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug.
Francesco Saverio Bersani,Ornella Corazza,Gabriella Albano,Giuseppe Valeriani,Rita Santacroce,Flaminia Bolzan Mariotti Posocco,Eduardo Cinosi,Pierluigi Simonato,Giovanni Martinotti,Giuseppe Bersani,Fabrizio Schifano +10 more
TL;DR: A comprehensive review of the nature and the risks associated with 25C-NBOMe, which has recently appeared in the drug market, and its use is increased by its online availability at low costs.